Open Access

The role of Zeb1 in the pathogenesis of morbidly adherent placenta

  • Authors:
    • Na Li
    • Tian Yang
    • Wenqian Yu
    • Hao Liu
    • Chong Qiao
    • Caixia Liu
  • View Affiliations

  • Published online on: July 12, 2019     https://doi.org/10.3892/mmr.2019.10490
  • Pages: 2812-2822
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Zinc finger E‑box‑binding homeobox 1 (Zeb1) is a promoter of epithelial‑mesenchymal transformation, which may serve an important role in morbidly adherent placenta (MAP). In the present study, the protein expression levels of Zeb1 were examined in the placenta tissues of 60 patients, including 20 patients with placenta accreta (PA) and 20 patients with placenta previa without PA (UPA) and 20 patients in late pregnancy that delivered by cesarean section (normal). The expression levels of Zeb1, N‑cadherin, vascular endothelial growth factor (VEGF), Tumor necrosis factor‑related apoptosis‑inducing ligand‑receptor 2 (TRAIL‑R2), and tumor necrosis factor‑related apoptosis‑inducing ligand‑receptor 3 (TRAIL‑R3) were higher in PA tissues compared with in normal control tissues. The expression levels of E‑cadherin and TRAIL‑R2 were decreased in PA tissues compared with in normal control tissues. These findings indicated that Zeb1 may serve an important role in placental attachment, thus promoting the development of dangerous PA. Overexpression of Zeb1 may upregulate the expression levels of N‑cadherin, VEGF, TRAIL‑R3, cyclin D1 and Bcl‑2, and downregulate the expression levels of E‑cadherin and TRAIL‑R2. In addition, Zeb1 regulated the viability, apoptosis and migration of HTR‑8/SV neo cells and human umbilical vein endothelial cells by regulating the Akt pathway. In conclusion, these findings indicated that Zeb1 may promote placental implantation by activating the Akt signaling pathway, thus providing a theoretical basis for investigating the causes of MAP.

References

1 

Roziana R, Kamarul Azhar K, Lau JH, Aina MAA, Nadia R, Siti Nordiana A and Mohd Zulkifli K: Morbidly adherent placenta: One-year case series in a tertiary hospital. Med J Malaysia. 74:128–132. 2019.PubMed/NCBI

2 

Balachandar K and Inglis E: The management of severe pre-eclampsia and HELLP syndrome in a twin pregnancy with a known morbidly adherent placenta: A case report. Case Rep Womens Health. 22:e001142019. View Article : Google Scholar : PubMed/NCBI

3 

Bamber JH and Sobers S: The Need to Consider the Women's Perspective: Neuraxial anesthesia and cesarean delivery for morbidly adherent placenta. Anesth Analg. 128:e56–e57. 2019. View Article : Google Scholar : PubMed/NCBI

4 

Lopes ES, Feitosa FEL, Brazil AV, de Castro JDV, da Costa JIF, Araujo Júnior E, Peixoto AB and Carvalho FHC: Assessment of sensitivity and specificity of ultrasound and magnetic resonance imaging in the diagnosis of placenta accreta. Rev Bras Ginecol Obstet. 41:17–23. 2019. View Article : Google Scholar : PubMed/NCBI

5 

Furukawa S, Fujisaki M, Maki Y, Oohashi M, Doi K and Sameshima H: Manual removal of placenta in women having unpredictable adherent placenta. J Obstet Gynaecol Res. 45:141–147. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Katzman PJ, Blitman J and Metlay LA: Basal chronic villitis and disorders of the placental basal plate: A possible immunological link between hypertensive disorders of pregnancy and morbidly adherent placenta. Pediatr Dev Pathol. Jan 21–2019.(Epub ahead of print). doi: 10.1177/1093526619825708. View Article : Google Scholar

7 

Wang Y, Wu Z and Hu L: The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer (CRC). Eur J Pharmacol. 834:45–53. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Egger JV, Lane MV, Antonucci LA, Dedi B and Krucher NA: Dephosphorylation of the retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb. Cancer Biol Ther. 17:1197–1205. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Mooney SM, Talebian V, Jolly MK, Jia D, Gromala M, Levine H and McConkey BJ: The GRHL2/ZEB Feedback Loop-A Key Axis in the regulation of EMT in breast cancer. J Cell Biochem. 118:2559–2570. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Noman MZ, Janji B, Abdou A, Hasmim M, Terry S, Tan TZ, Mami-Chouaib F, Thiery JP and Chouaib S: The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200. Oncoimmunology. 6:e12634122017. View Article : Google Scholar : PubMed/NCBI

11 

Ohashi S, Natsuizaka M, Naganuma S, Kagawa S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D, et al: A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res. 71:6836–6847. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Rhodes LV, Tate CR, Segar HC, Burks HE, Phamduy TB, Hoang V, Elliott S, Gilliam D, Pounder FN, Anbalagan M, et al: Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators. Breast Cancer Res Treat. 145:593–604. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Shu H, Chen H, Yang B, Chang Z, Xiong M and Chen W: Aberrant expression of E-cadherin and integrin β-1 in trophoblasts is associated with malignant gestational trophoblastic diseases. Int J Gynecol Cancer. 23:749–754. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Al-Khan A, Bulmer JN, Chantraine F, Chen CP, Chen Q, Collins S, Cotechini T, Fitzgerald JS, He M, Holland O, et al: IFPA Meeting 2012 Workshop Report III: Trophoblast deportation, gestational trophoblastic disease, placental insufficiency and fetal growth restriction, trophoblast over-invasion and accreta-related pathologies, placental thrombosis and fibrinolysis. Placenta. 34 (Suppl):S11–S16. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Wang Y, Jia L, Wang B, Diao S, Jia R and Shang J: MiR-495/IGF-1/AKT Signaling as a novel axis is involved in the Epithelial-to-Mesenchymal transition of oral squamous cell carcinoma. J Oral Maxillofac Surg. 77:1009–1021. 2019. View Article : Google Scholar : PubMed/NCBI

17 

Hu T, Lu MN, Chen B, Tong J, Mao R, Li SS, Dai P, Tan YX and Xiyang YB: Electro-acupuncture-induced neuroprotection is associated with activation of the IGF-1/PI3K/Akt pathway following adjacent dorsal root ganglionectomies in rats. Int J Mol Med. 43:807–820. 2019.PubMed/NCBI

18 

Kuang WH, Dong ZQ, Tian LT and Li J: IGF-1 defends against chronic-stress induced depression in rat models of chronic unpredictable mild stress through the PI3K/Akt/FoxO3a pathway. Kaohsiung J Med Sci. 34:370–376. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Zhang Q, Zhou L, Guan Y, Cheng Y and Han X: BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop. Chem Biol Interact. 294:18–27. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Matsubara S: Balloon uterine tamponade device after peripartum hysterectomy for morbidly adherent placenta. Obstet Gynecol. 133:1882019. View Article : Google Scholar : PubMed/NCBI

21 

Shmakov RG, Vinitskiy AA, Chuprinin VD, Yarotskaya EL and Sukhikh GT: Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery. J Matern Fetal Neonatal Med. 32:2042–2048. 2019. View Article : Google Scholar : PubMed/NCBI

22 

Shin JO, Nakagawa E, Kim EJ, Cho KW, Lee JM, Cho SW and Jung HS: miR-200b regulates cell migration via Zeb family during mouse palate development. Histochem Cell Biol. 137:459–470. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Kokkinos MI, Murthi P, Wafai R, Thompson EW and Newgreen DF: Cadherins in the human placenta-epithelial-mesenchymal transition (EMT) and placental development. Placenta. 31:747–755. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslén B, Marsál K and Hansson SR: Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta. 25:518–529. 2004. View Article : Google Scholar : PubMed/NCBI

25 

Duzyj CM, Buhimschi IA, Motawea H, Laky CA, Cozzini G, Zhao G, Funai EF and Buhimschi CS: The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin. Placenta. 36:645–651. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Incebiyik A, Kocarslan S, Camuzcuoglu A, Hilali NG, Incebiyik H and Camuzcuoglu H: Trophoblastic E-cadherin and TGF-beta expression in placenta percreta and normal pregnancies. J Matern Fetal Neonatal Med. 29:126–129. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Guimaraes GC, Alves LA, Betarelli RP, Guimarães CSO, Helmo FR, Pereira Júnior CD, Corrêa RRM and Zangeronimo MG: Expression of vascular endothelial growth factor (VEGF) and factor VIII in the gilt placenta and its relation to fetal development. Theriogenology. 92:63–68. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Klettner A, Kaya L, Flach J, Lassen J, Treumer F and Roider J: Basal and apical regulation of VEGF-A and placenta growth factor in the RPE/choroid and primary RPE. Mol Vis. 21:736–748. 2015.PubMed/NCBI

29 

Mathew S, Sundararaj S, Mamiya H and Banerjee I: Regulatory interactions maintaining self-renewal of human embryonic stem cells as revealed through a systems analysis of PI3K/AKT pathway. Bioinformatics. 30:2334–2342. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Lv WM, Zhao Y, Yang G, Dong SY, Zhang GH, Zhang Y, Li GZ and Cheng Y: Role of Ras, ERK, and Akt in glucocorticoid-induced differentiation of embryonic rat somatotropes in vitro. Mol Cell Biochem. 391:67–75. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Godoy-Parejo C, Deng C, Liu W and Chen G: Insulin stimulates PI3K/AKT and cell adhesion to promote the survival of individualized human embryonic stem cells. Stem Cells. Apr 25–2019.(Epub ahead of print). doi: 10.1002/stem.3026. View Article : Google Scholar : PubMed/NCBI

32 

Park JH and Han HJ: Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: Involvement of PI3K/Akt and ERK. Am J Physiol Cell Physiol. 297:C935–C944. 2009. View Article : Google Scholar : PubMed/NCBI

33 

Tan Y, Xin X, Coffey FJ, Wiest DL, Dong LQ and Testa JR: Appl1 and Appl2 are expendable for mouse development but are essential for HGF-Induced akt activation and migration in mouse embryonic fibroblasts. J Cell Physiol. 231:1142–1150. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 20 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, N., Yang, T., Yu, W., Liu, H., Qiao, C., & Liu, C. (2019). The role of Zeb1 in the pathogenesis of morbidly adherent placenta. Molecular Medicine Reports, 20, 2812-2822. https://doi.org/10.3892/mmr.2019.10490
MLA
Li, N., Yang, T., Yu, W., Liu, H., Qiao, C., Liu, C."The role of Zeb1 in the pathogenesis of morbidly adherent placenta". Molecular Medicine Reports 20.3 (2019): 2812-2822.
Chicago
Li, N., Yang, T., Yu, W., Liu, H., Qiao, C., Liu, C."The role of Zeb1 in the pathogenesis of morbidly adherent placenta". Molecular Medicine Reports 20, no. 3 (2019): 2812-2822. https://doi.org/10.3892/mmr.2019.10490